KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 77 filers reported holding KYMERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,555 | -29.6% | 2,486 | +16.5% | 0.00% | 0.0% |
| Q2 2023 | $49,061 | -22.4% | 2,134 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $63,230 | +6.4% | 2,134 | -10.3% | 0.00% | 0.0% |
| Q4 2022 | $59,405 | +19.4% | 2,380 | +4.2% | 0.00% | +50.0% |
| Q3 2022 | $49,744 | +10.6% | 2,285 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $44,992 | -53.5% | 2,285 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $96,701 | -83.6% | 2,285 | -75.3% | 0.00% | -62.5% |
| Q4 2021 | $588,298 | +8.1% | 9,266 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $544,285 | +31.1% | 9,266 | +8.2% | 0.01% | +33.3% |
| Q2 2021 | $415,257 | +236.1% | 8,562 | +169.3% | 0.01% | +200.0% |
| Q1 2021 | $123,536 | -37.3% | 3,179 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $197,098 | – | 3,179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |